Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
GL | -21.42% | $10.37B | -1.80% | 0.78% |
EAT | -14.26% | $7.11B | +258.81% | 0.00% |
OMCL | -14.10% | $1.86B | +42.14% | 0.00% |
GRMN | -13.67% | $40.37B | +69.59% | 1.42% |
LPTH | -12.66% | $113.05M | +78.13% | 0.00% |
ABBV | -12.31% | $341.85B | +9.55% | 3.25% |
GHI | -12.07% | $301.14M | -22.25% | 11.45% |
GIS | -11.31% | $32.82B | -5.93% | 3.97% |
BRSP | -9.86% | $769.03M | -13.30% | 12.06% |
KDP | -9.69% | $43.23B | +2.51% | 2.77% |
CPB | -9.52% | $11.51B | -6.47% | 3.86% |
EXEL | -9.34% | $9.65B | +67.51% | 0.00% |
BPT | -9.30% | $13.12M | -75.57% | 0.00% |
SYPR | -9.08% | $47.20M | +6.49% | 0.00% |
VUZI | -9.02% | $315.07M | +153.25% | 0.00% |
PULM | -8.71% | $27.36M | +307.07% | 0.00% |
WHF | -8.57% | - | - | 14.42% |
NRDS | -8.29% | $1.01B | -15.63% | 0.00% |
HSIC | -8.24% | $9.68B | +2.81% | 0.00% |
MO | -8.21% | $90.88B | +33.48% | 7.48% |
Finnhub
BERKELEY HEIGHTS, N.J., Jan. 21, 2025 -- CorMedix Inc. , a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions,...
Yahoo
‒ Q4 2024 Unaudited Net Revenue of Approximately $31mm ‒ ‒ FY 2024 Unaudited Net Revenue of Approximately $43mm ‒ ‒ Expects Q4 Adjusted EBITDA to Exceed $12mm ‒ BERKELEY HEIGHTS, N.J., Jan. 07, 2025 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, today announces its preliminary unaudited fourth quarter results and provides an update on its business. These inc
SeekingAlpha
CorMedix Inc.'s DefenCath shows considerable promise in reducing catheter-related bloodstream infections. Click here for this CRMD update.
Finnhub
CorMedix Inc. added to S&P Pharmaceuticals Select Industry Index...
Yahoo
RBC Capital raised the firm’s price target on CorMedix (CRMD) to $12 from $11 and keeps an Outperform rating on the shares. The company has had a productive 2024 with the launch of DefenCath ongoing, and the management has remained in execution mode, establishing commercial agreements with dialysis providers and operators, including the signing of a large dialysis organization, the analyst tells investors in a research note. As DefenCath’s launch matures, RBC sees signs of reduced ordering and l
Yahoo
BERKELEY HEIGHTS, N.J., Dec. 19, 2024 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, today announced it will be added to the Nasdaq Biotechnology Index (Nasdaq: NBI) (the “NBI”). CorMedix’s addition to the NBI will become effective prior to the market open on Monday, December 23, 2024. The NBI is designed to track the performance of a set of securities liste
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
UNF | 31.08% | $3.86B | +24.58% | 0.62% |
WING | 28.08% | $9.11B | -1.02% | 0.31% |
PRTA | 27.90% | $747.40M | -51.30% | 0.00% |
CLH | 27.85% | $12.46B | +24.42% | 0.00% |
BLKB | 27.62% | $4.10B | +11.77% | 0.00% |
YMAB | 27.26% | $276.35M | -61.44% | 0.00% |
ARCT | 26.95% | $444.50M | -57.03% | 0.00% |
SIGA | 26.25% | $432.00M | +26.11% | 0.00% |
DNLI | 25.88% | $3.07B | +16.07% | 0.00% |
ORA | 25.73% | $3.80B | -6.64% | 0.76% |
VERA | 25.22% | $2.16B | -24.90% | 0.00% |
SPRY | 25.10% | $1.16B | +64.19% | 0.00% |
SUNS | 24.69% | $80.33M | +2.65% | 5.40% |
CRBU | 24.60% | $118.62M | -81.29% | 0.00% |
ALLO | 24.17% | $295.64M | -71.57% | 0.00% |
AVNS | 23.84% | $764.26M | -15.58% | 0.00% |
MRCY | 23.70% | $2.72B | +49.93% | 0.00% |
PFGC | 23.35% | $13.74B | +20.12% | 0.00% |
CPAY | 23.35% | $25.68B | +33.78% | 0.00% |
GIC | 23.33% | $922.12M | -47.16% | 4.11% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
XBIO | <0.01% | $6.47M | +17.84% | 0.00% |
AKAM | -<0.01% | $14.97B | -10.67% | 0.00% |
FTDR | -0.01% | $4.46B | +77.40% | 0.00% |
MHK | 0.01% | $7.55B | +2.78% | 0.00% |
TTD | -0.05% | $40.43B | +8.20% | 0.00% |
ASPS | 0.06% | $31.31M | -59.51% | 0.00% |
BIO | -0.07% | $8.58B | -6.81% | 0.00% |
UTZ | -0.07% | $1.14B | -27.76% | 1.72% |
UVV | -0.08% | $1.33B | +5.30% | 6.01% |
MTB | -0.09% | $32.71B | +43.16% | 2.69% |
PG | 0.10% | $401.02B | +8.92% | 2.43% |
HRL | -0.10% | $15.67B | -1.96% | 3.97% |
GPN | -0.10% | $26.50B | -24.44% | 0.95% |
CBZ | -0.11% | $4.41B | +24.85% | 0.00% |
GIFI | -0.12% | $112.18M | +48.16% | 0.00% |
UL | 0.13% | $138.54B | +11.72% | 3.35% |
VRCA | -0.13% | $59.04M | -88.28% | 0.00% |
FLIC | -0.13% | $310.90M | +19.50% | 6.09% |
OLPX | 0.14% | $954.61M | -33.64% | 0.00% |
SBUX | 0.14% | $128.36B | +21.22% | 1.55% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
OILK | 0.01% | $73.97M | 0.69% |
BNO | -0.02% | $94.01M | 1% |
LQDW | -0.03% | $214.20M | 0.34% |
TBLL | -0.04% | $2.04B | 0.08% |
MMIT | -0.10% | $819.21M | 0.3% |
SHY | -0.11% | $23.07B | 0.15% |
CORN | -0.13% | $65.57M | 0.2% |
FLDR | 0.13% | $716.08M | 0.15% |
IAGG | 0.18% | $7.08B | 0.07% |
IBDQ | -0.19% | $3.19B | 0.1% |
USO | -0.20% | $1.12B | 0.6% |
BIV | -0.21% | $21.46B | 0.03% |
FTGC | 0.25% | $2.50B | 1.02% |
IBTL | -0.29% | $288.93M | 0.07% |
FMB | 0.30% | $2.04B | 0.65% |
FLIA | 0.30% | $619.25M | 0.25% |
PDBC | 0.37% | $4.78B | 0.59% |
UITB | -0.39% | $2.33B | 0.39% |
LDSF | 0.40% | $127.91M | 0.75% |
ICSH | 0.40% | $5.33B | 0.08% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BTAL | -15.57% | $277.56M | 1.43% |
VIXY | -14.86% | $195.31M | 0.85% |
TOTL | -13.94% | $3.40B | 0.55% |
TPMN | -13.80% | $34.10M | 0.65% |
TAIL | -13.55% | $62.82M | 0.59% |
SHYM | -9.27% | $286.68M | 0.35% |
KCCA | -9.20% | $102.53M | 0.87% |
JAAA | -8.19% | $21.11B | 0.21% |
SUB | -7.96% | $8.92B | 0.07% |
IBMN | -7.94% | $476.70M | 0.18% |
SHYD | -7.62% | $319.45M | 0.35% |
PWZ | -7.48% | $716.48M | 0.28% |
IBTF | -7.15% | $2.25B | 0.07% |
XONE | -6.95% | $576.97M | 0.03% |
BIL | -6.79% | $37.22B | 0.1356% |
UGA | -6.74% | $93.86M | 0.97% |
SPSK | -6.66% | $282.45M | 0.5% |
DFIP | -6.46% | $836.11M | 0.11% |
TLTW | -6.10% | $1.01B | 0.35% |
MMIN | -5.98% | $477.94M | 0.3% |
Current Value
$10.501 Year Return
Current Value
$10.501 Year Return
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
XBI | 27.00% | $5.92B | 0.35% |
PTH | 26.51% | $125.48M | 0.6% |
XPH | 26.36% | $164.02M | 0.35% |
EFAA | 26.08% | $107.21M | 0% |
CPRJ | 25.07% | $50.86M | 0.69% |
PINK | 22.81% | $142.29M | 0.5% |
IBB | 22.41% | $6.33B | 0.45% |
IWC | 22.14% | $956.01M | 0.6% |
QQQJ | 21.20% | $672.41M | 0.15% |
IWO | 21.14% | $12.47B | 0.24% |
ECH | 21.11% | $532.61M | 0.6% |
IHAK | 21.10% | $980.37M | 0.47% |
FNY | 21.00% | $424.53M | 0.7% |
XHE | 20.96% | $204.35M | 0.35% |
SIL | 20.96% | $1.26B | 0.65% |
IHDG | 20.90% | $2.98B | 0.58% |
CPNJ | 20.90% | $34.72M | 0.69% |
IHE | 20.77% | $617.22M | 0.39% |
VBK | 20.62% | $20.12B | 0.07% |
UFEB | 20.55% | $74.73M | 0.79% |